Product
Flu mRNA
Aliases
GSK4382276A
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
A Phase 1/2, Randomized, Dose-finding/Dose-confirmation Study to Evaluate the Reactogenicity, Safety and Immunogenicity of mRNA-based Multivalent Seasonal Influenza Vaccine Candidates Administered in Healthy Younger and Older AdultsStatus: Active (not recruiting), Estimated PCD: 2024-07-11